RNS Number : 0758F
GlaxoSmithKline PLC
05 January 2010
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of changes in the directors' interests in the Ordinary shares and American Depository Shares (ADSs) of GlaxoSmithKline plc.
On 31 December 2009, the Company's Non-Executive Directors were provisionally allocated the following awards over Ordinary shares and American Depository Shares (ADSs) in the Company through the annual reinvestment of dividends paid throughout 2009:
GlaxoSmithKline Non-Executive Directors Automatic Share Award and Elected Share Award - Annual Dividend Reinvestment
|
Non-Executive Director
|
No. of Ordinary Shares
|
Average
Price (£)
|
No. of
ADSs
|
Average Price ($)
|
|
Sir Christopher Gent
|
1,822.44
|
13.25
|
|
|
|
Prof Sir Roy Anderson
|
151.12
|
13.25
|
|
|
|
Dr Stephanie Burns
|
|
|
158.38
|
42.40
|
|
Mr Lawrence Culp
|
|
|
717.14
|
42.40
|
|
Sir Crispin Davis
|
1,501.48
|
13.25
|
|
|
|
Sir Deryck Maughan
|
|
|
628.85
|
42.40
|
|
Mr James Murdoch
|
2.13
|
13.25
|
|
|
|
Dr Daniel Podolsky
|
|
|
263.63
|
42.40
|
|
Mr Tom de Swaan
|
277.24
|
13.25
|
|
|
|
Sir Robert Wilson
|
424.27
|
13.25
|
|
|
The Company and the Non-Executive Directors were informed of these allocations on 4 January 2010.
This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
S M Bicknell
Company Secretary
5 January 2010
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSQELFBBFFXBBF